Dr. Williams on the Rationale for the SunRISE-2 Trial in Muscle-Invasive Bladder Cancer
Stephen B. Williams, MD, discusses the rationale for the phase 3 SunRISE-2 trial in muscle-invasive bladder cancer.
My Path to Fellowship: Slightly Different From Most
There is no magic door to walk through at the
end of our training (whether that be residency or
fellowship) that leads to the perfect job.
Dr Ganesan on the Use of ctDNA Assays For MRD Detection in Cancer Care
Dr Habib on Developments in Palliative Care For Patients With Cancer
Dr Boland on the Emergence of KRAS G12C Inhibitors in mCRC
Dr In on the Increased Incidence of Gastric Cancer in Minority Patient Populations
2 Clarke Drive Cranbury, NJ 08512